NCT02180191

Brief Summary

An altered gut microbiota composition has recently been linked to obesity and diabetes. The principal aim of this study was to investigate and compare the gut microbiota composition of obese, diabetic and control individuals. Then, associations between analyzed gut microbial concentrations and clinical-biochemical blood parameters were assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 2, 2014

Completed
Last Updated

July 2, 2014

Status Verified

July 1, 2014

Enrollment Period

8 months

First QC Date

July 1, 2014

Last Update Submit

July 1, 2014

Conditions

Keywords

Gut microbiota

Outcome Measures

Primary Outcomes (1)

  • The comparison of the gut microbiota composition

    The gut microbiota composition of obese, diabetic and control individuals was analyzed by quantitative real-time PCR (qRT-PCR)

    9 months

Secondary Outcomes (1)

  • The relationship between metabolic parameters and the gut microbiota composition

    9 months

Study Arms (3)

Obesity

27 obese individuals (20 men and 7 women with mean BMI: 39.98±5.56 kg/m2)

Other: Comparison of the gut microbiota composition

Diabetes

26 patients with newly diagnosed type 2 diabetes (18 men and 8 women with mean BMI: 28.63±5.08 kg/m2)

Other: Comparison of the gut microbiota composition

Control

Healthy control subjects (22 men and 6 women with mean BMI: 23.02±1.70 kg/m2)

Other: Comparison of the gut microbiota composition

Interventions

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Tertiary referral center

You may qualify if:

  • Subjects with obesity or newly diagnosed type 2 diabetes
  • years to 65 years of age

You may not qualify if:

  • Any chronic disease (other than obesity and diabetes)
  • Alcohol consumption/smoking
  • Pregnancy/breastfeeding
  • The use of antibiotics, pro-prebiotics within 3 months
  • \<18 years or \>65 years
  • History of intestinal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology and Metabolism, Gulhane School of Medicine

Ankara, 06180, Turkey (Türkiye)

Location

MeSH Terms

Conditions

ObesityDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

July 1, 2014

First Posted

July 2, 2014

Study Start

January 1, 2013

Primary Completion

September 1, 2013

Study Completion

September 1, 2013

Last Updated

July 2, 2014

Record last verified: 2014-07

Locations